<bill session="118" type="h" number="5905" updated="2025-11-18T21:32:15Z">
  <state datetime="2023-10-25">REFERRED</state>
  <status>
    <introduced datetime="2023-10-25"/>
  </status>
  <introduced datetime="2023-10-06"/>
  <titles>
    <title type="display">Federal Kratom Consumer Protection Act</title>
    <title type="short" as="introduced">Federal Kratom Consumer Protection Act</title>
    <title type="official" as="introduced">To protect access to kratom.</title>
  </titles>
  <sponsor bioguide_id="P000607"/>
  <cosponsors>
    <cosponsor bioguide_id="B001301" joined="2023-10-06"/>
  </cosponsors>
  <actions>
    <action datetime="2023-10-06">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-10-25" state="REFERRED">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2023-10-25">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To, Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="s" number="3039" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Advisory bodies"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Food supply, safety, and labeling"/>
    <term name="Government information and archives"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2024-01-24T19:03:43Z" status="Introduced in House">Federal Kratom Consumer Protection Act

This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.</summary>
</bill>
